What Do Q2 Insurer Investor Calls Tell Us?
Q2 2024 investor calls are coming to a close and we see mixed results on the part of insurers. Some insurers, such as Cigna (commercial-dominate, Alignment Healthcare (Medicare Advantage (MA)- dominant), Clover Health (MA-dominant), and Oscar Health (Exchange-dominant), have bucked negative trends.
On the other hand, CVS Health, Humana and Centene have been hurt by Medicare and Medicaid rates and cost pressures.
United remains dominate, but also reported cost pressures and costs from the Change Healthcare cyberattacks.
Elevance Health appears to be performing among the best, growing its services line and mitigating government program pressures with strong commercial performance.
#healthplans #insurers #healthcare #earnings
Ten States Are Holdouts On Medicaid Expansion And Are Largely In The Deep South
A good article recapping once positive efforts to expand Medicaid in the deep South, all of which failed during recent legislative sessions. The ten states have the ignominious distinction of having hundreds of thousands of citizens who are in a coverage gap — earning too much to qualify for Medicaid but not enough to enroll in the Exchanges and receive subsidies to help pay for coverage.
It is a huge inequity in America and needs to be solved.
(Article may require a subscription.)
#coveragegap #exchanges #medicaid #obamacare #aca #coverage
— Marc S. Ryan
